Department of Biochemistry and Molecular Genetics, The University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Chemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA; Program of Pharmacology, Weill Cornell Medical College of Cornell University, New York, NY 10021, USA.
Cell Rep. 2021 Jul 27;36(4):109421. doi: 10.1016/j.celrep.2021.109421.
Mitogen-activated protein kinases (MAPKs) are inactivated by dual-specificity phosphatases (DUSPs), the activities of which are tightly regulated during cell differentiation. Using knockdown screening and single-cell transcriptional analysis, we demonstrate that DUSP4 is the phosphatase that specifically inactivates p38 kinase to promote megakaryocyte (Mk) differentiation. Mechanistically, PRMT1-mediated methylation of DUSP4 triggers its ubiquitinylation by an E3 ligase HUWE1. Interestingly, the mechanistic axis of the DUSP4 degradation and p38 activation is also associated with a transcriptional signature of immune activation in Mk cells. In the context of thrombocytopenia observed in myelodysplastic syndrome (MDS), we demonstrate that high levels of p38 MAPK and PRMT1 are associated with low platelet counts and adverse prognosis, while pharmacological inhibition of p38 MAPK or PRMT1 stimulates megakaryopoiesis. These findings provide mechanistic insights into the role of the PRMT1-DUSP4-p38 axis on Mk differentiation and present a strategy for treatment of thrombocytopenia associated with MDS.
丝裂原活化蛋白激酶(MAPKs)可被双特异性磷酸酶(DUSPs)失活,其在细胞分化过程中的活性受到严格调控。通过敲低筛选和单细胞转录组分析,我们证明 DUSP4 是一种特异性失活 p38 激酶以促进巨核细胞(Mk)分化的磷酸酶。从机制上讲,PRMT1 介导的 DUSP4 甲基化触发其被 E3 连接酶 HUWE1 泛素化。有趣的是,DUSP4 降解和 p38 激活的机制轴也与 Mk 细胞中免疫激活的转录特征相关。在骨髓增生异常综合征(MDS)中观察到的血小板减少症的情况下,我们证明高水平的 p38 MAPK 和 PRMT1 与血小板计数低和预后不良相关,而抑制 p38 MAPK 或 PRMT1 的药理学抑制可刺激巨核细胞生成。这些发现为 PRMT1-DUSP4-p38 轴在 Mk 分化中的作用提供了机制见解,并为治疗与 MDS 相关的血小板减少症提供了一种策略。